Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents

James J. Li, Monica B. Norton, Emily J. Reinhard, Gary D. Anderson, Susan A. Gregory, Peter C. Isakson, Carol M. Koboldt, Jaime L. Masferrer, William E. Perkins, Karen Seibert, Yan Zhang, Ben S. Zweifel, David B. Reitz

Research output: Contribution to journalArticlepeer-review

129 Scopus citations


A novel series of terphenyl methyl sulfones and sulfonamides have been shown to be highly potent and selective cyclooxygenase-2 (COX-2) inhibitors. The sulfonamide analogs 17 and 21 were found to be much more potent COX-2 inhibitors and orally active anti-inflammatory agents than the corresponding methyl sulfone analogs 16 and 20, respectively, albeit with some decrease in COX-2 selectivity. Structure-activity relationship studies have determined that incorporation of two fluorine atoms in the central phenyl group, as in 20 and 21, is extremely advantageous for both in vitro COX-2 potency and selectivity as well as in vivo activity. Several noticeable examples in the 1,2-diaryl-4,5-difluorobenzenesulfonamide series are 21a-c,k,l,n (COX-2, IC50 = 0.002-0.004 μM), in which all have in vitro COX-1/COX-2 selectivity > 1000. In addition, sulfonamides 21a,b,d,g,j,m,n,q were shown to have greatly enhanced oral activity with more than 90% inhibition of prostaglandin E2 production in the air pouch model of inflammation. Furthermore, sulfonamide 21b was found to be very active in the rat adjuvant-induced arthritis model (ED50 = 0.05 mg/kg) and carrageenan-induced hyperalgesia assay (ED50 = 38.7 mg/kg) with no indication of gastrointestinal toxicity in rats at doses as high as 200 mg/kg.

Original languageEnglish
Pages (from-to)1846-1856
Number of pages11
JournalJournal of Medicinal Chemistry
Issue number9
StatePublished - Apr 26 1996


Dive into the research topics of 'Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents'. Together they form a unique fingerprint.

Cite this